Stay updated with breaking news from Roger Adsett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insmed Incorporated (NASDAQ:INSM – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $48.06, but opened at $46.00. Insmed shares last traded at $48.53, with a volume of 1,710,072 shares traded. Wall Street Analysts Forecast Growth A number of analysts recently issued reports on INSM shares. Mizuho […]
Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $50.10 and last traded at $46.74, with a volume of 10866167 shares trading hands. The stock had previously closed at $22.00. Wall Street Analyst Weigh In INSM has been the […]
Insmed Incorporated (NASDAQ:INSM – Get Free Report) COO Roger Adsett sold 7,857 shares of Insmed stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $25.50, for a total value of $200,353.50. Following the transaction, the chief operating officer now owns 155,220 shares of the company’s stock, valued […]
China Universal Asset Management Co. Ltd. raised its position in Insmed Incorporated (NASDAQ:INSM – Free Report) by 347.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,551 shares of the biopharmaceutical company’s stock after buying an additional 12,853 shares during […]
Wells Fargo & Company reissued their overweight rating on shares of Insmed (NASDAQ:INSM – Free Report) in a report released on Monday morning, Benzinga reports. The brokerage currently has a $55.00 price objective on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on INSM. Wolfe Research started coverage on shares of Insmed […]